Advertisement
Findings underscore need for racial diversity in ongoing and future trials
Investigative highlights include hormone therapies, biomarkers and early lifestyle interventions
69% relative risk reduction in large database analysis prompts plans for mechanistic and phase 2 studies
Links are centered on neuroinflammation and microvascular injury, network medicine study finds
Advertisement
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy
Both are essential, say updated International Working Group recommendations
New NIH-funded study tests home-based intervention in high-risk group
A screening blood test would be a huge step toward earlier intervention
Machine learning algorithm also screens for reversible causes of cognitive decline
NIA grant helps establish Nevada exploratory Alzheimer’s Disease Research Center
$2 million will enable preclinical dose and efficacy testing of “compound 3”
Advertisement
Advertisement